Correlation Between Dianthus Therapeutics and COSCIENS Biopharma
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and COSCIENS Biopharma, you can compare the effects of market volatilities on Dianthus Therapeutics and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and COSCIENS Biopharma.
Diversification Opportunities for Dianthus Therapeutics and COSCIENS Biopharma
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dianthus and COSCIENS is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and COSCIENS Biopharma go up and down completely randomly.
Pair Corralation between Dianthus Therapeutics and COSCIENS Biopharma
Given the investment horizon of 90 days Dianthus Therapeutics is expected to generate 1.06 times more return on investment than COSCIENS Biopharma. However, Dianthus Therapeutics is 1.06 times more volatile than COSCIENS Biopharma. It trades about -0.08 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.26 per unit of risk. If you would invest 2,828 in Dianthus Therapeutics on September 4, 2024 and sell it today you would lose (258.00) from holding Dianthus Therapeutics or give up 9.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dianthus Therapeutics vs. COSCIENS Biopharma
Performance |
| Timeline |
| Dianthus Therapeutics |
| COSCIENS Biopharma |
Dianthus Therapeutics and COSCIENS Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dianthus Therapeutics and COSCIENS Biopharma
The main advantage of trading using opposite Dianthus Therapeutics and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.| Dianthus Therapeutics vs. Candel Therapeutics | Dianthus Therapeutics vs. Cingulate Warrants | Dianthus Therapeutics vs. Unicycive Therapeutics | Dianthus Therapeutics vs. Cardio Diagnostics Holdings |
| COSCIENS Biopharma vs. Candel Therapeutics | COSCIENS Biopharma vs. Cingulate Warrants | COSCIENS Biopharma vs. Unicycive Therapeutics | COSCIENS Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |